Ratings by H.C. Wainwright (Andrew Fein)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/1/2021 I-Mab IMAB Maintain Buy
(N/A)
 
 
  Details
8/16/2021 Aprea APRE Maintain Neutral
(N/A)
 
 
  Details
8/4/2021 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
7/26/2021 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
6/18/2021 Sutro Biopharma STRO New Coverage Buy
(N/A)
18.73
(19.68)
5.07% Details
6/10/2021 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
6/7/2021 Unity Biotechnology Inc UBX New Coverage Buy
(N/A)
4.56
(3.03)
-33.55% Details
6/4/2021 Protera Therapeutics TARA New Coverage Buy
(N/A)
9.26
(7.24)
-21.81% Details
6/4/2021 C4 Therapeutics CCCC New Coverage Buy
(N/A)
38.15
(49.95)
30.93% Details
5/6/2021 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
5/5/2021 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
4/13/2021 Pulmatrix PULM Maintain Buy
(N/A)
 
 
  Details
3/30/2021 Matinas BioPharma Holdings Inc. MTNB Maintain Buy
(N/A)
 
 
  Details
3/18/2021 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
3/3/2021 I-Mab IMAB Maintain Buy
(N/A)
 
 
  Details
2/10/2021 Kalvista Pharmaceuticals Inc KALV Maintain Buy
(N/A)
 
 
  Details
2/2/2021 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
2/2/2021 Concert Pharmaceuticals CNCE Maintain Buy
(N/A)
 
 
  Details
2/1/2021 United Therapeutics Corp. UTHR Upgrade Buy
(Neutral)
163.82
(200.08)
22.13% Details
12/14/2020 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
12/7/2020 Prothena Corp PRTA New Coverage Buy
(N/A)
11.53
(77.07)
568.43% Details
12/7/2020 I-Mab IMAB New Coverage Buy
(N/A)
37.99
(75.85)
99.66% Details
11/6/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
11/4/2020 Syros Pharmaceuticals SYRS Upgrade Buy
(Neutral)
7.58
(5.08)
-32.98% Details
8/20/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
8/4/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
7/31/2020 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
7/31/2020 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
6/26/2020 BELLUS Health Inc. BLU New Coverage Buy
(N/A)
9.62
(6.03)
-37.32% Details
6/26/2020 Merus N.V. MRUS New Coverage Buy
(N/A)
15.80
(25.63)
62.22% Details
6/25/2020 United Therapeutics Corp. UTHR Maintain Neutral
(N/A)
 
 
  Details
6/24/2020 Alector Inc. ALEC New Coverage Buy
(N/A)
31.02
(26.81)
-13.57% Details
6/24/2020 Cortexyme Inc. CRTX New Coverage Buy
(N/A)
49.26
(87.79)
78.22% Details
6/22/2020 Aprea APRE New Coverage Neutral
(N/A)
37.90
(5.06)
-86.65% Details
6/17/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
6/15/2020 Kalvista Pharmaceuticals Inc KALV New Coverage Buy
(N/A)
10.41
(19.25)
84.92% Details
5/4/2020 Keros Therapeutics KROS New Coverage Buy
(N/A)
28.80
(30.73)
6.7% Details
4/29/2020 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
3/11/2020 Sunesis Pharmaceuticals Inc. SNSS Maintain Neutral
(N/A)
 
 
  Details
3/6/2020 Eloxx Pharma ELOX Maintain Neutral
(N/A)
 
 
  Details
3/6/2020 Fulcrrum Therapeutics FULC Maintain Buy
(N/A)
 
 
  Details
3/6/2020 Syros Pharmaceuticals SYRS Maintain Neutral
(N/A)
 
 
  Details
2/25/2020 Epizyme EPZM Maintain Buy
(N/A)
 
 
  Details
2/19/2020 Bellerophon Therapeutics BLPH Maintain Buy
(N/A)
 
 
  Details
2/18/2020 Acasti Pharma ACST Maintain Buy
(N/A)
 
 
  Details
2/12/2020 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
12/19/2019 Aimmune Therapeutics AIMT New Coverage Neutral
(N/A)
31.61
(34.49)
9.11% Details
12/19/2019 Arvinas Inc. ARVN New Coverage Buy
(N/A)
40.84
(96.48)
136.24% Details
12/10/2019 AC Immune SA ACIU Maintain Buy
(N/A)
 
 
  Details
11/15/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
10/30/2019 Seattle Genetics SGEN Maintain Buy
(Buy)
 
 
  Details
10/23/2019 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
10/22/2019 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
10/3/2019 Concert Pharmaceuticals CNCE Maintain Buy
(N/A)
 
 
  Details
10/3/2019 PhaseBio Pharmaceuticals Inc. PHAS New Coverage Buy
(N/A)
4.03
(2.89)
-28.29% Details
10/3/2019 Deciphera DCPH New Coverage Buy
(N/A)
34.15
(32.98)
-3.43% Details
10/3/2019 Fulcrrum Therapeutics FULC New Coverage Buy
(N/A)
6.59
(30.83)
367.83% Details
10/3/2019 Blueprint Medicines BPMC New Coverage Buy
(N/A)
72.92
(106.00)
45.36% Details
7/3/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
6/26/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
6/26/2019 Denali Therapeutics Inc. DNLI New Coverage Buy
(N/A)
19.63
(52.83)
169.13% Details
6/26/2019 Acasti Pharma ACST New Coverage Buy
(N/A)
1.05
(2.19)
108.57% Details
6/26/2019 Matinas BioPharma Holdings Inc. MTNB New Coverage Buy
(N/A)
0.81
(1.10)
35.8% Details
6/26/2019 Rubius RUBY New Coverage Buy
(N/A)
13.71
(20.89)
52.37% Details
4/16/2019 Pulmatrix PULM Maintain Buy
(N/A)
 
 
  Details
4/1/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
3/25/2019 Biogen BIIB Maintain Buy
(Buy)
 
 
  Details
3/19/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
12/26/2018 Corbus Pharmaceuticals CRBP New Coverage Buy
(N/A)
5.28
(1.02)
-80.68% Details
12/26/2018 Neurometrix Inc. NURO New Coverage Buy
(N/A)
0.70
(11.34)
1520% Details
12/24/2018 Translate Bio TBIO New Coverage Buy
(N/A)
7.37
(37.36)
406.92% Details
12/24/2018 Eloxx Pharma ELOX New Coverage Neutral
(N/A)
12.89
(1.87)
-85.49% Details
12/20/2018 AnaptysBio ANAB New Coverage Buy
(N/A)
62.21
(26.92)
-56.73% Details
12/20/2018 Unum Therapeutics UMRX New Coverage Buy
(N/A)
4.74
(2.35)
-50.42% Details
12/20/2018 Sunesis Pharmaceuticals Inc. SNSS New Coverage Neutral
(N/A)
0.30
(5.32)
1673.33% Details
12/20/2018 MEI Pharma MEIP New Coverage Buy
(N/A)
2.16
(2.69)
24.54% Details
12/20/2018 Constellation Pharmaceuticals CNST New Coverage Buy
(N/A)
5.90
(33.99)
476.1% Details
12/13/2018 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
11/12/2018 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
10/26/2018 Vertex VRTX Upgrade Buy
(Neutral)
163.09
(188.30)
15.46% Details
9/25/2018 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
8/13/2018 BioCryst Pharma BCRX Maintain Buy
(N/A)
 
 
  Details